Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
AGIOS PHARMACEUTICALS, INC. | Chief Financial Officer | Common stock | 20.2K | $988K | $49.03 | Sep 26, 2024 | Direct |
AGIOS PHARMACEUTICALS, INC. | Chief Financial Officer | Restricted stock units | 7.47K | $319K | $42.75 | Sep 26, 2024 | Direct |
LogicBio Therapeutics, Inc. | Chief Financial Officer | Stock Option (right to buy) | 112K | Mar 1, 2022 | Direct | ||
AGIOS PHARMACEUTICALS, INC. | Chief Financial Officer | Stock options (right to buy) | 60K | Mar 1, 2024 | Direct | ||
AGIOS PHARMACEUTICALS, INC. | Chief Financial Officer | Performance share units | 0 | $21.64 | Jan 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AGIO | AGIOS PHARMACEUTICALS, INC. | Sep 26, 2024 | 3 | -$125K | 4 | Sep 30, 2024 | Chief Financial Officer |
AGIO | AGIOS PHARMACEUTICALS, INC. | Mar 1, 2024 | 5 | -$21.9K | 4 | Mar 5, 2024 | Chief Financial Officer |
AGIO | AGIOS PHARMACEUTICALS, INC. | Jan 20, 2024 | 3 | -$40.8K | 4 | Jan 24, 2024 | Chief Financial Officer |
AGIO | AGIOS PHARMACEUTICALS, INC. | Sep 26, 2023 | 3 | -$54K | 4 | Sep 28, 2023 | Chief Financial Officer |
AGIO | AGIOS PHARMACEUTICALS, INC. | Jun 28, 2023 | 3 | -$45.3K | 4 | Jun 30, 2023 | Chief Financial Officer |
AGIO | AGIOS PHARMACEUTICALS, INC. | Mar 1, 2023 | 2 | $0 | 4 | Mar 3, 2023 | Chief Financial Officer |
AGIO | AGIOS PHARMACEUTICALS, INC. | Sep 26, 2022 | 2 | $0 | 4 | Sep 28, 2022 | Chief Financial Officer |
AGIO | AGIOS PHARMACEUTICALS, INC. | Sep 26, 2022 | 0 | $0 | 3 | Sep 28, 2022 | Chief Financial Officer |
LOGC | LogicBio Therapeutics, Inc. | Mar 1, 2022 | 1 | $0 | 4 | Mar 3, 2022 | Chief Financial Officer |
LOGC | LogicBio Therapeutics, Inc. | Jan 11, 2022 | 3 | -$4.37K | 4 | Jan 13, 2022 | Chief Financial Officer |